Evidence map›Paper›PMID 28323486›Full record

ArticleNutrition and cancer

Enterolactone Induces G

Shireen Chikara, Kaitlin Lindsey, Harsharan Dhillon, Sujan Mamidi, Jeffrey Kittilson, Melpo Christofidou-Solomidou, Katie M Reindl

Open access · greenAbstract read
In one paragraph

Article in Nutrition and cancer. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. [Expression of CDC25A in non-small cell lung cancer and its relationship with let-7 gene].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2020
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shireen Chikaraa Department of Biological Sciences , North Dakota State University , Fargo , North Dakota , USA.
Kaitlin Lindseya Department of Biological Sciences , North Dakota State University , Fargo , North Dakota , USA.
Harsharan Dhillona Department of Biological Sciences , North Dakota State University , Fargo , North Dakota , USA.
Sujan Mamidib Department of Plant Sciences , North Dakota State University , Fargo , North Dakota , USA.
Jeffrey Kittilsona Department of Biological Sciences , North Dakota State University , Fargo , North Dakota , USA.
Melpo Christofidou-Solomidouc Department of Medicine , University of Pennsylvania , Philadelphia , Pennsylvania , USA.
Katie M Reindla Department of Biological Sciences , North Dakota State University , Fargo , North Dakota , USA.
North Dakota State University · USUniversity of Pennsylvania · US

Funding

Pilot Projects: Core DP30GM103332 · NIGMS · NORTH DAKOTA STATE UNIVERSITY · PI SIBI, MUKUND P. · 2012 to 2016
$4.9M
NIGMS NIH HHS P30 GM103332
6 · The paper itself

Abstract

Flaxseed is a rich source of the plant lignan secoisolariciresinol diglucoside (SDG), which is metabolized into mammalian lignans enterodiol (ED) and enterolactone (EL) in the digestive tract. The anticancer properties of these lignans have been demonstrated for various cancer types, but have not been studied for lung cancer. In this study, we investigated the anticancer effects of EL for several nonsmall cell lung cancer (NSCLC) cell lines of various genetic backgrounds. EL inhibited the growth of A549, H441, and H520 lung cancer cells in concentration- and time-dependent manners. The antiproliferative effects of EL for lung cancer cells were not due to enhanced cell death, but rather due to G

Indexed as

4-ButyrolactoneAntineoplastic Agents, PhytogenicCarcinoma, Non-Small-Cell LungCell Line, TumorCell ProliferationCyclin-Dependent KinasesCyclinsDose-Response Relationship, DrugDown-RegulationG1 Phase Cell Cycle CheckpointsGene Expression Regulation, NeoplasticHumansLignansLung Neoplasms2,3-bis(3'-hydroxybenzyl)butyrolactone4-ButyrolactoneAntineoplastic Agents, PhytogenicCyclin-Dependent KinasesCyclinsLignans

Identifiers

PMID28323486
PMCPMC5500210
OpenAlexW2598965843

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.